摘要:
The invention provides a polynucleotide in substantially isolated form which includes a contiguous sequence of nucleotides which is capable of selectively hybridizing to SEQ ID NO: 1 or the complement of SEQ ID NO: 1, and a polypeptide in substantially isolated form which includes: (a) the protein in SEQ ID NO: 2; or (b) an allelic variant or species homologue thereof; or (c) a protein at least 70% homologous to (a); or (d) a fragment of any one of (a) to (c) capable of forming a complex with the E2 F-1 protein or related family member; or (e) a fragment of any one of (a) to (c) of at least 15 amino acids.
摘要翻译:本发明提供了基本上分离形式的多核苷酸,其包括能够与SEQ ID NO:1或SEQ ID NO:1的互补序列选择性杂交的连续核苷酸序列和基本上分离形式的多肽,其包括:(a )SEQ ID NO:2中的蛋白质; 或(b)等位基因变体或其物种同系物; 或(c)与(a)至少70%同源的蛋白质; 或(d)能够与E2F-1蛋白质或相关家族成员形成复合物的(a)至(c)中任一项的片段; 或(e)至少15个氨基酸的(a)至(c)中任一项的片段。
摘要:
The invention provides a polynucleotide in substantially isolated form which comprises a contiguous sequence of nucleotides which is capable of selectively hybridizing to Seq. ID No. 1 or to the complement of Seq. ID No. 1, and a polypeptide in substantially isolated form which comprises: (a) the protein of Seq. ID No. 2; or (b) an allelic variant or species homologue thereof; or c) a protein at least 70% homologous to (a); or (d) a fragment of any one of (a) to (c) capable of forming a complex with the E2F-1 protein or related family member; or (e) a fragment of any one of (a) to (c) of at least 15 amino acids.
摘要:
The invention provides a polynucleotide in substantially isolated form which includes a contiguous sequence of nucleotides which is capable of selectively hybridizing to SEQ ID NO: 1 or the complement of SEQ ID NO: 1, and a polypeptide in substantially isolated form which includes: (a) the protein in SEQ ID NO: 2; or (b) an allelic variant or species homologue thereof; or (c) a protein at least 70% homologous to (a); or (d) a fragment of any one of (a) to (c) capable of forming a complex with the E2 F-1 protein or related family member; or (e) a fragment of any one of (a) to (c) of at least 15 amino acids.
摘要翻译:本发明提供了基本上分离形式的多核苷酸,其包括能够与SEQ ID NO:1或SEQ ID NO:1的互补序列选择性杂交的连续核苷酸序列和基本上分离形式的多肽,其包括:(a )SEQ ID NO:2中的蛋白质; 或(b)等位基因变体或其物种同系物; 或(c)与(a)至少70%同源的蛋白质; 或(d)能够与E2F-1蛋白质或相关家族成员形成复合物的(a)至(c)中任一项的片段; 或(e)至少15个氨基酸的(a)至(c)中任一项的片段。
摘要:
The invention provides an isolated nucleic acid (SEQ ID NO:1) encoding a novel protein, JMY, which is found to be a co-activator of p300/CBP. The invention also provides JMY polypeptides and antibodies thereto, as well as assays for modulators of the cell cycle which target the interaction of JMY with transcription factors such as E2F; ER or TBP.
摘要翻译:本发明提供了编码新型蛋白质JMY的分离的核酸(SEQ ID NO:1),其被发现是p300 / CBP的共激活剂。 本发明还提供JMY多肽及其抗体,以及针对JMY与转录因子如E2F的相互作用的细胞周期调节剂的测定; ER或TBP。
摘要:
The present invention is based upon the finding that the protein p300 has acetylation activity which is directed to the retinoblastoma tumour suppressor protein pRb by the presence in the cell of the adenovirus E1A protein. This represents a target for modulators of the cell cycle, to which end the invention provides an assay for a modulator of acetylation of pRb by p300, which comprises: a) bringing into contact a p300 protein a pRb protein and a putative modulator compound under conditions where the p300 protein, in the absence of said modulator is capable of acetylating the pRb protein; b) providing conditions for acetylation of said pRb protein; and c) measuring the degree of inhibition of acetylation caused by said modulator compound.
摘要:
The invention provides an isolated nucleic acid (SEQ ID NO:1) encoding a novel protein, JMY, which is found to be a co-activator of p300/CBP. The invention also provides JMY polypeptides and antibodies thereto, as well as assays for modulators of the cell cycle which target the interaction of JMY with transcription factors such as E2F, ER or TBP.
摘要翻译:本发明提供了编码新型蛋白质JMY的分离的核酸(SEQ ID NO:1),其被发现是p300 / CBP的共激活剂。 本发明还提供JMY多肽及其抗体,以及针对JMY与转录因子例如E2F,ER或TBP的相互作用的细胞周期调节剂的测定。